Accuray Incorporated to Present at 20th Annual Piper Jaffray Health Care ...( SUNNYVALE Calif. Nov. 24 /- Accuray I...),Health
Navigation Links
Accuray Incorporated to Present at 20th Annual Piper Jaffray Health Care Conference
Date:11/24/2008
SUNNYVALE, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the 20th Annual Piper Jaffray Health Care Conference in New York City, on Wednesday, December 3, 2008 at 9:00 a.m. EST (6:00 a.m. PST).
A live webcast of the presentation will be available online from the investor relations page of the Company's Web site at http://www.accuray.com. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.
About the CyberKnife(R) Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a
global leader in the field of radiosurgery dedicated to providing an improved
quality of life and a non-surgical treatment option for those diagnosed with
cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery
System, which extends the benefits of radiosurgery to include e
'/>"/>
| SOURCE Accuray Incorporated Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q
2. Accuray Incorporated Ranked Fifth in Deloittes Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment, and Biotechnology Companies
3. Accuray Incorporated to Speak at Oppenheimer Healthcare Conference
4. Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results
5. Accuray Incorporated Announces Resignation of Chief Financial Officer
6. Accuray Incorporated to Report Fourth Quarter and Fiscal Year 2008 Financial Results
7. Accuray Incorporateds CEO to Speak at Jefferies Second Annual Healthcare Conference
8. Accuray Incorporateds CEO to Present at Morgan Stanley 2008 Global Healthcare Unplugged Conference
9. Accuray Incorporated to Report Third Quarter Fiscal Year 2008 Financial Results
10. Accurays CFO to Present at B. Riley & Company Ninth Annual Investor Conference
11. Accurays CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
Post Your Comments:
(Date:11/27/2009)...nt Health™ announced today that Spectrum Hea...maCad Enterprise orthopedic templating solution an... (PRWEB) November 27, 2009 -- Vo...ealth (Grand Rapids, Michigan) has licensed its Tr...and its TraumaCad Extend workflow solution, to all...
(Date:11/27/2009)...e new interactive anatomy education apps from Moda...health sciences learning opportunities for iPhone ...NC (Vocus) November 27, 2009 -- Modality, Inc. a...sion of Wolters Kluwer Health, today announced the...on the App Store. Clemente’s Anatomy, Rohen&...
(Date:11/26/2009)...mber of Americans living with diabetes will nearly...4.1 million in 2034. Over the same period, spendin... billion to $336 billion, even with no increase in...he University of Chicago report in the December is...th diabetes covered by Medicare will rise from 8.2...
(Date:11/26/2009)...on an emotional rollercoaster, study finds , ...it the fear factor meets the jubilant sports fan. ...ially those who root for the winning team -- enjoy...sted match and victory was in doubt, producing fee... this Thanksgiving weekend as you,re glued to the ...
(Date:11/26/2009)...arch Triangle Dental (RTDental), a leading dental ...nounced the expansion of its services to include L... Macmillan. , Durham, ...to announce that Dr. Doug Macmillan, an experience...ional advanced training seminar. RTDental’s...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2[0] Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend[0] Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store[0] Diabetes cases to double and costs to triple by 2034[0] Watching the Nail-Biting Big Game Hurts So Good[0] Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental
...ts first patient in a 60-patient Phase 2 clinical ...e peroxidase mimetic, in diabetic patients with a...risk for cardiovascular complications.
This ... cardiovascular events.
It builds on posit...
...) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) to...tion (sNDA) for Nexavar(R) (sorafenib) tablets ha...tration (FDA) for the treatment of patients with h... advanced kidney cancer. The companies also confir...
...VI) today announced the results of work on genome ... one type of bacteria into another type dictated b...lished online in the journal Science, by JCVI's Ca...oplasma mycoides Large Colony (LC), by replacing o...
...ar effect to antidepressants on depression. Exerci...series of scientific reports, she has searched for... why exercise can be a form of therapy for depress... that both exercise and antidepressants increase t...
...es to smoke tobacco are waging an 11th-hour bid fo...rce in England on Sunday.
Without the shi...riously called, dozens of restaurants will lose th... are blocked with an 11-years lease signed in 2003...
...Friday it had withdrawn an application for regulat... the United States.
A panel of experts fr...arlier this month that the dieting treatment, refe... rimonabant file to the FDA at a future date," the...
Other Medicine News:Health News:Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2 2Health News:Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer 2Health News:First Bacterial Genome Transplantation Changing One Species to Another 2Health News:Shisha Owners Mobilise Against July 1 Smoking Ban in England 2Health News:Shisha Owners Mobilise Against July 1 Smoking Ban in England 3Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver CancerFirst Bacterial Genome Transplantation Changing One Species to AnotherNew Braincells can Be Induced by ExerciseShisha Owners Mobilise Against July 1 Smoking Ban in EnglandSanofi Withdraws Anti-obesity Drug in US
(Date:11/27/2009)... , Another option to prevent illnesses ca...ILVER SPRING, Md., Nov. 27 /PRNewswire-USNewswire/...proved Agriflu for people ages 18 years and older ...pes A and B. ,, (Logo: http://www.newscom.co...anufactured by Novartis Vaccines and Diagnostics i...
(Date:11/25/2009)... , CANOGA PARK, Calif., Nov. 25 /PRNewswire/ ...t place rankings in the American Academy of Family...M) 2009 EHR User Satisfaction Survey for improving...management, all critical for new ARRA Stimulus leg...cating their EMR had a positive effect in determin...
(Date:11/25/2009)... , PHILADELPHIA, Nov. 25 /PRNewswire-First...t Dr. Michael J. McKelvey, the Company,s President...ve Vice President and CFO, are scheduled to presen...ference at 1:30 PM EST on December 1, 2009 in New ...access the presentation by visiting the Company,s ...
Breaking Medicine Technology:FDA Approves Agriflu Seasonal Influenza Vaccine 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 1GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 2GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 3GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 4Demand for Short Term Medical Help Leads to Growth for Travel Nursing Staffing Agency 3B Prompts Move to New Location and Addition of New Online Tools 51782 1Demand for Short Term Medical Help Leads to Growth for Travel Nursing Staffing Agency 3B Prompts Move to New Location and Addition of New Online Tools 51782 2CNCB Post Graduate Studies in Clinical Nutrition 28PGSCN 29 Program is Now Available Online 51778 1CNCB Post Graduate Studies in Clinical Nutrition 28PGSCN 29 Program is Now Available Online 51778 2... of Antidote Component, ORLANDO, Fla., Nov. 4 Re...mized, double-blind, placebo-controlled Phase Ic,s... REG1 is a two-component,system comprised of an ap...antidote, RB007, which binds to and neutralizes RB...reverse the anticoagulant effect of RB006 either,c...
...PARK, N.C., Nov. 2 /PRNewswire/,-- Fabre-Kramer Ph...: GSK ),announced today that the U.S. Food and Dr...e letter for the new drug application for gepirone... treatment of adults with major,depressive disorde...h III clinical data,involving gepirone ER. In June...
Other Medicine Technology:Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions 2Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions 3Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |